Sethy V H, Day J S, Cooper M M
Res Commun Chem Pathol Pharmacol. 1986 Oct;54(1):35-46.
The effects of intravenous infusion of desipramine (1, 3, 10, and 60 mg/kg/24 hr), amitriptyline, zimelidine, iprindole (3, 10, 30, 60, and 100 mg/kg/24 hr each), imipramine (10, 30, and 100 mg/kg/24 hr), or U-48,753E (1, 3, 10, and 30 mg/kg/24 hr) on the density of central beta-adrenergic receptors were investigated in Sprague-Dawley rats. A comparative study with oral desipramine (3 mg/kg/24 hr) for 74 hrs was also carried out. Desipramine, amitriptyline, zimelidine, iprindole, imipramine, and U-48,753E reduced the density of beta-adrenergic receptors in the cerebral cortex, and the effect seems to be dose-dependent. In the oral study, desipramine failed to down-regulate beta-adrenergic receptors. These results indicate that down-regulation of beta-adrenergic receptors can be rapidly achieved by intravenous infusion of drugs.
在斯普拉格-道利大鼠中,研究了静脉输注去甲丙咪嗪(1、3、10和60毫克/千克/24小时)、阿米替林、齐美利定、茚满丙二胺(各3、10、30、60和100毫克/千克/24小时)、丙咪嗪(10、30和100毫克/千克/24小时)或U - 48,753E(1、3、10和30毫克/千克/24小时)对中枢β-肾上腺素能受体密度的影响。还进行了一项口服去甲丙咪嗪(3毫克/千克/24小时)持续74小时的对比研究。去甲丙咪嗪、阿米替林、齐美利定、茚满丙二胺、丙咪嗪和U - 48,753E降低了大脑皮质中β-肾上腺素能受体的密度,且这种作用似乎呈剂量依赖性。在口服研究中,去甲丙咪嗪未能下调β-肾上腺素能受体。这些结果表明,通过静脉输注药物可迅速实现β-肾上腺素能受体的下调。